Sybilla Biotech: in-silico drug discovery

MIB Lens Deep Tech Stories by MIB Trieste
Thursday 28th May, 6:00 pm

MIB Lens web workshops is proud to host the series “Deep Tech Stories”, that focuses on real business cases: companies founded on a scientific discovery or a disruptive technological innovation, aiming to achieve exponential results in new markets through the creative vision of their entrepreneurs.

The series “MIB Lens Deep Tech Stories” has been authored together with Venture Factory, the number one deep-tech and technology transfer investor in Italy, and MIB partner on the EMBA IN program.  The entrepreneurs will be interviewed by the Venture Factory investors, so the perspectives that will emerge form the meetings will be absolutely hands on and genuine.

The upcoming webinar focuses on the Sybilla Biotech business case: their founder-scientists have developed the most advanced platform for in-silico drug discovery. The innovation is based on applying innovative algorithms derived from advanced mathematical methods of theoretical physics to transformative drug discovery protocols.

Session in English language.

more info